Home

Sun Pharmaceutical Industries PE Ratio

Image

Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA

PE

35.5

Last updated on: May 10, 2025

Key Highlights

  • The P/E Ratio of Sun Pharmaceutical Industries Ltd is 35.5 as of 10 May 13:58 PM .
  • The P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 40.6 on March 2024 . This represents a CAGR of 12.53% over 5 years.
  • The Latest Trading Price of Sun Pharmaceutical Industries Ltd is ₹ 1744 as of 09 May 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.1. The PE Ratio of Pharmaceuticals industry is 40.1. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Sun Pharmaceutical Industries Ltd

No data available

Company Fundamentals for Sun Pharmaceutical Industries Ltd

Image

Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA

Share Price

₹ 1744.85

-21.35 (-1.21%)

stock direction

Last updated on: May 09, 2025

Market Price of Sun Pharmaceutical Industries Ltd

1M

1Y

3Y

5Y

Monitoring Sun Pharmaceutical Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 May 20251744.85
08 May 20251766.2
07 May 20251781.35
06 May 20251818.75
05 May 20251835.15
02 May 20251828.75
30 Apr 20251830.2
29 Apr 20251804.8
28 Apr 20251841.8
25 Apr 20251786.85

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Sun Pharmaceutical Industries Ltd

Asset Value vs Market Value of Sun Pharmaceutical Industries Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Sun Pharmaceutical Industries Ltd418647
Divis Laboratories Ltd159310
Cipla Ltd119410
Torrent Pharmaceuticals Ltd106184
Mankind Pharma Ltd99570
Dr Reddys Laboratories Ltd96496

PE Ratio of Sun Pharmaceutical Industries Ltd Explained

418647

Market cap

11433

Earnings

35.5X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Sun Pharmaceutical Industries Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Sun Pharmaceutical Industries Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Sun Pharmaceutical Industries Ltd

No data available

* All values are in %

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Sun Pharmaceutical Industries Ltd News Hub

Sun Pharmaceuticals Industries Ltd spurts 0.31%, up for fifth straight session

Sun Pharmaceuticals Industries Ltd gained for a fifth straight session today. The stock is quoting a

Read more

20 Aug 24

Sun Pharmaceutical to invest USD 15 mn in Pharmazz Inc.

Sun Pharmaceutical Industries has entered into an agreement with Pharmazz Inc. Delaware US, pursuant

Read more

14 Aug 24

Sun Pharma Q1 PAT climbs 40% YoY to Rs 2,835 cr

Profit before tax was at Rs 3,423.5 crore in Q1 FY25, registering a growth of 37.98% on YoY basis. D

Read more

01 Aug 24

Sun Pharmaceuticals Industries consolidated net profit rises 40.20% in the June 2024 quarter

Net profit of Sun Pharmaceuticals Industries rose 40.20% to Rs 2835.62 crore in the quarter ended Ju

Read more

01 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Sun Pharmaceutical Industries Ltd

What is the current PE Ratio of Sun Pharmaceutical Industries Ltd?

The Current PE Ratio of Sun Pharmaceutical Industries Ltd is 35.49 as on 10 May 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.1 as on 10 May 2025.

What was the PE Ratio of Sun Pharmaceutical Industries Ltd last year?

The PE Ratio of Sun Pharmaceutical Industries Ltd was 27.83 last year, now the PE ratio is 35.49, showing a year-on-year growth of 27.5%.

What does the PE Ratio of Sun Pharmaceutical Industries Ltd indicate about its stock?

The PE Ratio of Sun Pharmaceutical Industries Ltd is 35.49. This ratio indicates that investors are willing to pay 35.49 times the earnings per share for each share of Sun Pharmaceutical Industries Ltd.

What is the PE Ratio Growth of Sun Pharmaceutical Industries Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Sun Pharmaceutical Industries Ltd grew by 27.5% whereas, the EPS ratio grew by -4.7.

How does the PE ratio of Sun Pharmaceutical Industries Ltd compare to industry peers?

The PE ratio of Sun Pharmaceutical Industries Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Sun Pharmaceutical Industries Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Sun Pharmaceutical Industries Ltd PE Ratio.

What factors influence the PE ratio of Sun Pharmaceutical Industries Ltd PE Ratio?

The PE ratio of Sun Pharmaceutical Industries Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Sun Pharmaceutical Industries Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Sun Pharmaceutical Industries Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Sun Pharmaceutical Industries Ltd PE Ratio?

You can check the latest PE ratio of Sun Pharmaceutical Industries Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Sun Pharmaceutical Industries Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Sun Pharmaceutical Industries Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Sun Pharmaceutical Industries Ltd PE Ratio predict future stock performance?

While the Sun Pharmaceutical Industries Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions